Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 3:10 pm Purchase | 2022-12-31 | 13G | BioAtla, Inc. BCAB | Cormorant Asset Management LP | 3,680,365 7.980% | 1,642,150 (+80.57%) | Filing History |
| 2023-02-14 3:10 pm Purchase | 2022-12-31 | 13G | Aerovate Therapeutics, Inc. AVTE | Cormorant Asset Management LP | 1,957,132 7.950% | 126,441 (+6.91%) | Filing History |
| 2023-02-14 3:09 pm Sale | 2022-12-31 | 13G | Cabaletta Bio, Inc. CABA | Cormorant Asset Management LP | 1,971,739 6.770% | -28,261 (-1.41%) | Filing History |
| 2023-02-14 3:08 pm Sale | 2022-12-31 | 13G | Arcellx, Inc. ACLX | Cormorant Asset Management LP | 2,075,000 4.730% | -125,000 (-5.68%) | Filing History |
| 2023-02-14 3:08 pm Sale | 2022-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA | Cormorant Asset Management LP | 2,082,000 5.150% | -87,871 (-4.05%) | Filing History |
| 2023-02-14 3:07 pm Sale | 2022-12-31 | 13G | Altimmune, Inc. ALT | Cormorant Asset Management LP | 2,600,000 5.290% | -400,000 (-13.33%) | Filing History |
| 2023-02-14 3:05 pm Sale | 2022-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | Cormorant Asset Management LP | 1,100,000 2.730% | -336,322 (-23.42%) | Filing History |
| 2023-02-14 3:05 pm Purchase | 2022-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH | Cormorant Asset Management LP | 1,801,947 9.990% | 420,015 (+30.39%) | Filing History |
| 2023-02-14 3:04 pm Purchase | 2022-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | Cormorant Asset Management LP | 1,736,422 6.510% | 333,091 (+23.74%) | Filing History |
| 2023-02-14 3:03 pm Purchase | 2022-12-31 | 13G | Astria Therapeutics, Inc. ATXS | Cormorant Asset Management LP | 1,650,000 6.300% | 450,000 (+37.50%) | Filing History |
| 2023-02-14 3:03 pm Sale | 2022-12-31 | 13G | VectivBio Holding AG VECT | Cormorant Asset Management LP | 2,536,617 4.040% | -303,772 (-10.69%) | Filing History |
| 2023-02-14 3:02 pm Sale | 2022-12-31 | 13G | Tango Therapeutics, Inc. TNGX | Cormorant Asset Management LP | 4,116,949 4.670% | -782,235 (-15.97%) | Filing History |
| 2023-02-14 3:01 pm Sale | 2022-12-31 | 13G | Prometheus Biosciences, Inc. RXDX | Cormorant Asset Management LP | 2,090,000 4.500% | -134,847 (-6.06%) | Filing |
| 2023-02-14 3:00 pm Sale | 2022-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN | Cormorant Asset Management LP | 1,391,663 9.990% | -36,935 (-2.59%) | Filing History |
| 2022-12-29 4:15 pm Purchase | 2022-12-19 | 13G | 89bio, Inc. ETNB | Cormorant Asset Management LP | 2,550,000 5.480% | 2,550,000 (New Position) | Filing History |
| 2022-12-27 4:15 pm Purchase | 2022-12-14 | 13G | Avidity Biosciences, Inc. RNA | Cormorant Asset Management LP | 2,762,115 5.070% | 750,000 (+37.27%) | Filing History |
| 2022-12-21 4:32 pm Purchase | 2022-12-13 | 13D | Erasca, Inc. ERAS | Cormorant Asset Management LP | 10,893,107 7.260% | 387,554 (+3.69%) | Filing History |
| 2022-10-31 4:01 pm Purchase | 2022-10-20 | 13G | Cabaletta Bio, Inc. CABA | Cormorant Asset Management LP | 2,000,000 7.810% | 845,576 (+73.25%) | Filing History |
| 2022-09-02 4:10 pm Purchase | 2022-08-23 | 13G | Astria Therapeutics, Inc. ATXS | Cormorant Asset Management LP | 1,200,000 5.380% | 1,200,000 (New Position) | Filing History |
| 2022-08-29 4:00 pm Purchase | 2022-08-18 | 13G | Arcellx, Inc. ACLX | Cormorant Asset Management LP | 2,200,000 5.020% | 2,200,000 (New Position) | Filing History |